Bio-Rad launches Anti-Pertuzumab Antibodies
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, introduces four inhibitory antibodies that are highly specific to pertuzumab (Perjeta).
Antiverse collaborates with top 20 pharma company to identify antibody drug candidates using AI Augmented Drug Discovery platform
Antiverse’s platform accurately identified diverse and rare antibodies. The project demonstrates potential of Antiverse’s platform to reduce time and costs associated with antibody drug discovery.
H.E.L Group appoints Rajeev Kumria as General Manager of H.E.L India
Experienced General Manager and commercial leader will scale H.E.L's operations in Indian growth markets, including biotechnology, process safety, and pharmaceutical industries. The appointment will enable H.E.L India to provide direct sales and marketing, service, and support operations to customers locally.
Avacta selects second pre|CISION™ pro-drug candidate for development
Cambridge and Wetherby, UK: Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms announces that the next pre|CISION™ drug candidate, AVA3996, has been selected for pre-clinical development with a view to a first-in-human Phase I clinical trial beginning…
Insightful Science acquires Omiq to add cloud-based machine learning to its flow cytometry capabilities
OMIQ is a powerful flow cytometry SaaS solution adopted by leading global biopharma labs.
The Native Antigen Company expands range of Norovirus-like particles
Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the expansion of its norovirus-like particle range, with the addition of six new reagents, including four which are unique to the market. These virus-like…
NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
Shenzhen, China and Cambridge, UK: NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, have announced an oncology drug discovery research collaboration.
H.E.L Group expands operations in India
H.E.L India opening further strengthens H.E.L's global presence with regional hub-based service and customer support. Expansion will focus on supporting high growth industries in India, including biotechnology, process safety, and pharmaceutical industries
Avacta provides update on AffiDX® SARS-CoV-2 antigen lateral flow test and detection of the Omicron variant
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, provides an update on the performance of the AffiDX® SARS-CoV-2 antigen lateral flow test (LFT) with the Omicron variant.
Samsara Therapeutics establishes Scientific Advisory Board
Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics.
Avacta announces AffiDX® SARS-CoV-2 antigen lateral flow test receives CE mark for consumer self-testing
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces that the AffiDX® SARS-CoV-2 antigen lateral flow test has received a CE mark for use as a consumer self-test in the UK and EU.
Insightful Science acquires Protein Metrics to expand its R&D solution to include proteomics
San Diego, CA, 21 December 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire Protein Metrics Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the Company’s R&D value chain to widen the biopharmaceutical…
Bio-Rad introduces Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex™ Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays, for research use only (RUO). The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant…
Avacta announces AffiDx SARS-CoV-2 antigen lateral flow test detects the Omicron variant
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms is pleased to announce that the AffiDX® antigen lateral flow test has been shown to detect the Omicron variant of the SARS-CoV-2 virus in clinical samples.
FUJIFILM Irvine Scientific opens European manufacturing facility
SANTA ANA, California, December 8, 2021: FUJIFILM Irvine Scientific, Inc., today announced that its new manufacturing facility in Tilburg, the Netherlands is now open and fully operational. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan to enable increased production capacity of cell culture media products; acting as a hub for…
Sixfold Bioscience completes $10.5M USD (£7.8M GBP) seed financing
London, UK, 02 Dec 2021: Sixfold Bioscience (Sixfold), a company harnessing computation and advanced chemistry to design RNA therapeutic delivery systems, today announced it has raised a total of $10.5 million USD (£7.8 million GBP) in its seed funding round. The funding will support the continued development of the Company’s Mergo® RNA therapeutics delivery platform.
Avacta announces FDA approval of its Investigational New Drug (IND) application for AVA6000
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AVA6000. This will allow the Group to expand its Phase I clinical…
Rebeca Sanchez Sarmiento joins Insightful Science and Dotmatics as Chief Financial Officer
Appointment brings extensive financial industry experience to drive global growth and build corporate value of newly combined organization that is aiming to make the world a healthier, cleaner and better place to live.
Bio-Rad introduces StarBright UltraViolet 400 Dye for flow cytometry
StarBright UltraViolet 400 Dye offers maximal brightness and narrow excitation and emission profiles for precise resolution.
CrestOptics acquired by Apposite Capital LLP to enable rapid commercial growth and innovation in bioimaging
Investment from Apposite Capital LLP will accelerate CrestOptics’ commercial expansion into new markets globally, and enable further development of innovative cell imaging products.
Insightful Science acquires LabArchives to expand its electronic lab notebook and LIMS solutions for scientific discovery
San Diego, CA, 10th November 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire LabArchives.
FUJIFILM Irvine Scientific expands its Armstrong R&D Cell Culture Center of Excellence to accelerate new product development
SANTA ANA, California, November 10, 2021: FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene therapy,…
BioNet and Sartorius’ company BIA Separations collaborate on production process development of mRNA vaccines
Ajdovšcina, Slovenia & Bangkok, Thailand, 02 November 2021: BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, today announced the successful development of an optimized mRNA manufacturing process.
Bio-Rad launches its CFX Opus Dx real-time PCR detection systems for in vitro diagnostics
HERCULES, Calif.––Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been listed with the US Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD use in…
H.E.L Group releases latest update to labCONSOL automation software with enhanced calibration and process safety functionality
London, UK, 18 October 2021: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the release of the latest version of its laboratory automation software, labCONSOL™ 1.2. The new functionality included in the update further enhances the intuitive user experience to increase lab productivity and…